This result could be partially explained by a compensatory mechanism, in which IL-10 plasma levels increase as a consequence of higher plasma levels of proinflammatory cytokines INF-γ, TNF-α, and IL-6 in patients with nephropathy to regulate the inflammatory status, since IL-10 is an anti-inflammatory cytokine. This evidence concerns the gene IL6 and kidney disorder.